Anti-inflammatory effect of Euphorbia supina extract in dextran sulfate sodium-induced colitis mice

References

• Andoh A, Shioya M, Nishida A, et al. Expression of IL-24, an activator of the JAK1/STAT3/SOCS3 cascade, is enhanced in inflammatory bowel disease. J. Immunology. 2009;183(1):687–695.10.4049/jimmunol.0804169
   PubMed Web of Science ®Google Scholar
• Sands BE. Inflammatory bowel disease : past, present, and future. J. Gastroenterol. 2007;42(1):16–25.10.1007/s00535-006-1995-7
   PubMed Web of Science ®Google Scholar
• Mizoguchi A, Mizoguchi E. Inflammatory bowel disease, past, present and future : lessons from animal models. J. Gastroenterol. 2008;43(1):1–17.10.1007/s00535-007-2111-3
   PubMed Web of Science ®Google Scholar
• Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm bowel dis. 2006; 12(supple):S3–S910.1097/01.MIB.0000195385.19268.68
   PubMed Web of Science ®Google Scholar
• Rutgeerts P. Protagonist: Crohn’s disease recurrence can be prevented after ileal resection. Gut. 2002;51(2):152–153.10.1136/gut.51.2.152
   PubMed Web of Science ®Google Scholar
• Nagura H, Ohtani H, Sasano H, et al. The immuno-inflammatory mechanism for tissue injury in inflammatory bowel disease and Helicobacter pylori-infected chronic active gastritis. Roles of the mucosal immune system. Digestion. 2001;63(1):12–21.10.1159/000051905
   PubMed Web of Science ®Google Scholar
• Ludwiczek O, Vannier E, Borggraefe I, et al. Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease. Clin Exp Immunol. 2004;138(2):323–329.10.1111/cei.2004.138.issue-2
   PubMed Web of Science ®Google Scholar
• Podolsky DK. Inflammatory bowel disease. N. engl. J. Med. 1991;325(14):417–429.
   Web of Science ®Google Scholar
• Danese S, Semeraro S, Marini M, et al. Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation. Dig Liver Dis. 2005;37(11):811–818.10.1016/j.dld.2005.03.013
   PubMedGoogle Scholar
• Kumar GK, Dhamotharan R, Kulkarni NM, et al. Embelin ameliorates dextran sodium sulfate-induced colitis in mice. Int Immunopharmacol. 2011;11(6):724–731.10.1016/j.intimp.2011.01.022
   PubMed Web of Science ®Google Scholar
• Xu C, Meng SY, Pan BR. Drug therapy for ulcerative colitis. World J gastroenterol. 2004;10(16):2311–2317.10.3748/wjg.v10.i16.2311
   PubMed Web of Science ®Google Scholar
• Matsuoka K, Mizuno S, Hayashi A, et al. Fecal microbiota transplantation for gastrointestinal diseases. Keio J Med. 2014;63(4):69–74.10.2302/kjm.2014-0006-RE
   PubMedGoogle Scholar
• Chen WX, Ren LH, Shi RH. Enteric microbiota leads to new therapeutic strategies for ulcerative colitis. World J Gastroenterol. 2014;20(42):15657–15663.10.3748/wjg.v20.i42.15657
   PubMed Web of Science ®Google Scholar
• Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014;109(7):1065–1071.10.1038/ajg.2014.133
   PubMed Web of Science ®Google Scholar
• Langhorst J, Wulfert H, Lauche R, et al. Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases. J Crohns Colitis. 2015;9(1):86–106.10.1093/ecco-jcc/jju007
   PubMed Web of Science ®Google Scholar
• Ng SC, Lam YT, Tsoi KK, et al. Systematic review: the efficacy of herbal therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38(8):854–863.10.1111/apt.2013.38.issue-8
   PubMed Web of Science ®Google Scholar
• Wan P, Chen H, Guo Y, et al. Advances in treatment of ulcerative colitis with herbs: from bench to bedside. World J Gastroenterol. 2014;20(39):14099–14104.10.3748/wjg.v20.i39.14099
   PubMed Web of Science ®Google Scholar
• Wang TT, Zhou GH, Kho JH, et al. Vasorelaxant action of an ethylacetate fraction of Euphorbia humifusa involves NO-cGMP pathway and potassium channels. J Ethnopharmacol. 2013;148(2):655–663.10.1016/j.jep.2013.05.025
   PubMed Web of Science ®Google Scholar
• Ogata H, Hibi T. Cytokine and anti-cytokine therapies for inflammatory bowel disease. Curr Pharm Des. 2003;9(14):1107–1113.10.2174/1381612033455035
   PubMed Web of Science ®Google Scholar
• Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med. 2000;51:589–598.
   Web of Science ®Google Scholar
• Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology. 1994;106(2):533–539.10.1016/0016-5085(94)90614-9
   PubMed Web of Science ®Google Scholar
• Malizia G, Calabrese A, Cottone M, et al. Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease. Gastroenterology. 1991;100(1):150–159.10.1016/0016-5085(91)90595-C
   PubMed Web of Science ®Google Scholar
• Simmonds NJ, Allen RE, Stevens TRJ, et al. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology. 1992;103(1):186–196.10.1016/0016-5085(92)91112-H
   PubMed Web of Science ®Google Scholar
• Rachmilewitz D, Stamler JS, Bachwich D, et al. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn’s disease. Gut. 1995;36(5):718–723.10.1136/gut.36.5.718
   PubMed Web of Science ®Google Scholar
• Kang OH, Kim DK, Cai XF, et al. Attenuation of experimental murine colitis by acanthoic acid from Acanthopanax koreanum. Arch Pharm Res. 2010;33(1):87–93.10.1007/s12272-010-2230-x
   PubMed Web of Science ®Google Scholar
• Murthy SN, Cooper HS, Shim H, et al. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporine. Dig Dis Sci. 1993;38(9):1722–1734.10.1007/BF01303184
   PubMed Web of Science ®Google Scholar
• Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98(3):694–702.10.1016/0016-5085(90)90290-H
   PubMed Web of Science ®Google Scholar
• Dharmani P, Chadee K. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key. Curr Mol Pharmacol. 2008;1(3):195–212.10.2174/1874467210801030195
   PubMedGoogle Scholar
• Wu LH, Xu ZL, Dong D, et al. Protective effect of anthocyanins extract from blueberry on TNBS-induced IBD model of mice. Evid Based Complement Alternat Med. 2011;2011:525462.
   PubMed Web of Science ®Google Scholar
• Ishiguro Y, Ohkawara T, Sakuraba H, et al. Macrophage migration inhibitory factor has a proinflammatory activity via the p38 pathway in glucocorticoid-resistant ulcerative colitis. Clin Immunol. 2006;120(3):335–341.10.1016/j.clim.2006.05.010
   PubMed Web of Science ®Google Scholar
• Sandborn WJ, Targan SR. Biologic therapy of inflammatory bowel disease. Gastroenterology. 2002;122(6):1592–1608.10.1053/gast.2002.33426
   PubMed Web of Science ®Google Scholar
• Rufo PA, Bousvaros A. Current therapy of inflammatory bowel disease in children. Paediatr Drugs. 2006;8(5):279–302.10.2165/00148581-200608050-00002
   PubMedGoogle Scholar
• Morita I. Distinct functions of COX-1 and COX-2. Prostaglandins Other Lipid Mediat. 2002;68–69:165–175.10.1016/S0090-6980(02)00029-1
   PubMed Web of Science ®Google Scholar
• Lauritsen K, Laursen LS, Kjeldsen J, et al. Effects of mesalazine on the formation of lipoxygenase and cyclooxygenase products. Adv Exp Med Biol. 1995;371B:1301–1306.
   PubMedGoogle Scholar
• Perkins ND, Gilmore TD. Good cop, bad cop: the different faces of NF-κB. Cell Death Differ. 2006;13(5):759–772.10.1038/sj.cdd.4401838
   PubMed Web of Science ®Google Scholar
• Hayden MS, Ghosh S. Signaling to NF-κB. Genes Dev. 2004;18(18):2195–2224.10.1101/gad.1228704
   PubMed Web of Science ®Google Scholar
• Kovacs-Nolan J, Zhang H, Ibuki M, et al. The PepT1-transportable soy tripeptide VPY reduces intestinal inflammation. Biochim Biophys Acta. 2012;1820(11):1753–1763.10.1016/j.bbagen.2012.07.007
   PubMed Web of Science ®Google Scholar
• Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001;104(4):487–501.10.1016/S0092-8674(01)00237-9
   PubMed Web of Science ®Google Scholar
• Rose-John S, Waetzig GH, Scheller J, et al. The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets. 2007;11(5):613–624.10.1517/14728222.11.5.613
   PubMed Web of Science ®Google Scholar